Portada

HUMAN ANTIBODY THERAPEUTICS FOR VIRAL DISEASE IBD

SPRINGER
10 / 2007
9783540721444
Inglés

Sinopse

Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. Only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure.

PVP
208,40